Kent, United Kingdom

Robert James Crook

USPTO Granted Patents = 5 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 62(Granted Patents)


Location History:

  • Sandwich, GB (2001 - 2004)
  • Kent, GB (2001 - 2006)
  • Sandwich, Kent CT13 9NJ, GB (2006)

Company Filing History:


Years Active: 2001-2006

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Robert James Crook

Introduction

Robert James Crook is a notable inventor based in Kent, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as opiate binding agents. With a total of 5 patents to his name, Crook's work has had a meaningful impact on therapeutic applications.

Latest Patents

Among his latest patents, Crook has developed "3-azabicyclo[3.1.0]hexane derivatives useful in therapy." This patent describes compounds that act as opiate binding agents, which are beneficial in treating opiate-mediated conditions. Additionally, he has patented a "Process for the production of quinazolines," which outlines a method for creating a specific compound and its pharmaceutically acceptable salts or solvates.

Career Highlights

Throughout his career, Robert James Crook has worked with prominent organizations, including Pfizer Corporation. His experience in the pharmaceutical industry has allowed him to refine his expertise and contribute to innovative solutions in drug development.

Collaborations

Crook has collaborated with several notable individuals in his field, including Alan John Pettman and Bernard Joseph Banks. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications.

Conclusion

Robert James Crook's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…